EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TIMELESS promotes glioma stemness and malignancy through JAK-STAT3 pathway

Yuichiro Kai, Akito Tsuruta, Takuto Inoki, Tomoaki Yamauchi, Shigehiro Ohdo, Satoru Koyanagi

Journal of Biological Chemistry · 2026

DOI: 10.1016/j.jbc.2026.113447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Yuichiro Kai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Glioma, Neoplastic Stem Cells, Cell Cycle Proteins. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gliomas are the most common primary tumors of the central nervous system. Among them, glioblastoma (GBM), a World Health Organization (WHO) grade 4 glioma, is the most aggressive form and remains one of the most lethal human cancers. Its poor prognosis is largely attributable to rapid progression, frequent recurrence, and profound therapeutic resistance, all of which are closely associated with glioma stem cells (GSCs). Although several signaling pathways sustaining GSC properties have been identified, upstream regulators that coordinate these pathways remain incompletely understood. TIMELESS, originally identified as a component of the circadian clock, has recently been implicated in the regulation of brain function and is aberrantly overexpressed in multiple cancer types; however, its role in glioma malignancy has not been defined. Here, we demonstrate that TIMELESS mRNA expression increases with glioma grade and is associated with poor prognosis across multiple glioma cohorts. Genetic depletion of Timeless suppressed tumor aggressiveness and prolonged survival in an orthotopic mouse glioma model by attenuating GSC properties. Mechanistically, TIMELESS enhanced stemness of glioma by upregulating Janus kinases (JAK) expression and promoting phosphorylation of signal transducer and activator of transcription 3 (STAT3). These effects were conserved in human GBM cells, supporting the relevance of TIMELESS-mediated signaling across species. Together, our findings uncover an unexpected, clock-independent function of TIMELESS in sustaining glioma stemness and malignancy and highlight the TIMELESS-JAK-STAT3 axis as a noncanonical mechanism that operates beyond the traditional circadian clockwork in treatment-resistant glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorGliomaNeoplastic Stem CellsCell Cycle ProteinsIntracellular Signaling Peptides and ProteinsJanus KinasesBrain NeoplasmsHumansAnimalsSignal TransductionMiceCell Line, Tumor

Stichwörter der Autor:innen

JAK-STAT3TIMELESScancer stem cellsclock geneglioma

Substanzen

STAT3 Transcription FactorCell Cycle ProteinsSTAT3 protein, humanIntracellular Signaling Peptides and ProteinsTIMELESS protein, humanJanus Kinases

Autor:innen und Institutionen

  • Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: tsuruta@phar.kyushu-u.ac.jp.
  • Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: koyanagi@phar.kyushu-u.ac.jp.

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency

Zitieren

APA

Kai, Y., Tsuruta, A., Inoki, T., Yamauchi, T., Ohdo, S., & Koyanagi, S. (2026). TIMELESS promotes glioma stemness and malignancy through JAK-STAT3 pathway. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.113447

Vancouver

Kai Y, Tsuruta A, Inoki T, Yamauchi T, Ohdo S, Koyanagi S. TIMELESS promotes glioma stemness and malignancy through JAK-STAT3 pathway. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.113447

BibTeX
@article{Kai2026,
  author = {Kai, Yuichiro and Tsuruta, Akito and Inoki, Takuto and Yamauchi, Tomoaki and Ohdo, Shigehiro and Koyanagi, Satoru},
  title = {TIMELESS promotes glioma stemness and malignancy through JAK-STAT3 pathway},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  doi = {10.1016/j.jbc.2026.113447}
}
Kostenlos starten →